BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3415269)

  • 1. [A study of CDDP in the treatment of patients with gastric and esophageal cancers, with special reference to the evaluation of renal functions before and after CDDP administration].
    Sasaki E; Namatame K; Hirose C; Hamai N; Onomura Y; Miyata N; Kusumoto S; Makuuchi M; Iwai H; Asakawa K
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2713-7. PubMed ID: 3415269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
    Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
    Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of fractionated low dose Cisplatin on renal functions of patients with gastric carcinoma].
    Li Y; Shen L; Li J; Jin ML
    Ai Zheng; 2007 Dec; 26(12):1354-6. PubMed ID: 18076800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
    Ujiie T; Maruta H; Ito N
    Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy with low-dose CDDP and continuous 5-FU for the treatment of advanced gastric cancers].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):933-8. PubMed ID: 10396320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in renal function on response to rapid administration of cisplatinum].
    Mikata N; Suzuki M; Takeuchi T; Kunisawa Y; Fukutani K; Kawabe K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):508-13. PubMed ID: 3954374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of synchronous esophageal and gastric cancer successfully treated by combination TS-1/CDDP therapy with irradiation].
    Takemura M; Osugi H; Lee S; Taguchi S; Kaneko M; Tanaka Y; Fukuhara K; Fujiwara Y; Nishizawa S; Kinoshita H; Harada S
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):251-4. PubMed ID: 14997762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transition of renal function after repeated intraperitoneal CDDP administration].
    Arai K; Kitamura M; Iwasaki Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1476-8. PubMed ID: 8854784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
    Nishimura G; Horiuchi C; Yoshida T; Kawakami M; Yabuki K; Taguchi T; Nagao J; Kondo N; Masuda Y; Matsuda H; Mikami Y; Tsukuda M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):463-6. PubMed ID: 16612154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with 5-FU modulated by low-dose CDDP for advanced cancers and recurrent cases of metastasis].
    Shinkai K; Kida H; Hisano H; Shibasaki S; Yano H; Nomura M
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):329-32. PubMed ID: 10065096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
    Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complete response in a case of simultaneous esophageal and gastric cancer treated by combined radiotherapy and chemotherapy of TS-1 and CDDP].
    Iwase H; Kaida S; Nakamura M; Mizuno T; Iyo T; Nakarai K; Indo T; Hiraiwa A
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):455-9. PubMed ID: 11915739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive effect of prostaglandin E1 on cisplatin-induced nephrotoxicity].
    Takayama K; Nakanishi Y; Takano K; Harada T; Inoue K; Osaki S; Minami T; Hara N
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):503-8. PubMed ID: 10097747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylactic effect of fosfomycin on CDDP nephrotoxicity].
    Yogi S; Ikeuchi T; Kai Y
    Hinyokika Kiyo; 1989 Apr; 35(4):615-21. PubMed ID: 2735267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction].
    Hirosawa A; Sakai S; Iizuka K; Niitani H; Hayashibara K; Tsuboi E
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2870-5. PubMed ID: 3662543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute change in urinary NAG activity following CDDP administration].
    Yoshida K; Takahashi T; Nakame Y; Saitoh H; Horiuchi S; Kaneoya F; Negishi T
    Hinyokika Kiyo; 1986 Mar; 32(3):369-73. PubMed ID: 3728241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of bismuth subnitrate on cisplatin toxicity].
    Chen JT; Kurokawa Y; Nakayama K; Saito K; Sakamoto K; Fukuda K; Hirai Y; Hamada T; Fujimoto I; Yamauchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):815-22. PubMed ID: 3298471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
    Nakata B; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
    Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.